These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2988310)

  • 1. Thromboxane and leukotrienes in clinical and experimental transplant rejection.
    Foegh ML; Alijani MR; Helfrich GB; Khirabadi BS; Goldman MH; Lower RR; Ramwell PW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():209-17. PubMed ID: 2988310
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
    Foegh ML; Lim K; Douglas F; Turk J; Helfrich GB; Taher SA; Alijani MR
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):424-7. PubMed ID: 3279631
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
    Punnonen K; Uotila P; Mäntylä E
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor.
    Teraoka S; Takahashi K; Toma H; Ota K
    Transplant Proc; 1993 Apr; 25(2):2085-6. PubMed ID: 8470279
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.
    Lefer AM; Okamatsu S; Smith EF; Smith JB
    Thromb Res; 1981 Aug; 23(3):265-73. PubMed ID: 6795758
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
    Kitamura S; Ishihara Y; Takaku F
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):3-8. PubMed ID: 6539836
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4.
    Schilling M; Holzinger F; Friess H; Seiler C; Büchler MW
    Transplant Proc; 1996 Feb; 28(1):304-5. PubMed ID: 8644233
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor.
    Cerletti C; Rajtar G; Bertelé V; de Gaetano G
    Thromb Haemost; 1984 Oct; 52(2):215. PubMed ID: 6441306
    [No Abstract]   [Full Text] [Related]  

  • 11. T cell subset analysis and immune monitoring of kidney transplant recipients experiencing reversal or nonreversal of steroid-resistant rejection by plasma leukapheresis.
    Pennline KJ; Edwards MG; White S; Gelfand M; Helfrich GB
    Transplant Proc; 1984 Dec; 16(6):1550-4. PubMed ID: 6390862
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term renal preservation and prevention of acute tubular necrosis by inhibition of arachidonate metabolism.
    Schilling M; Saunder A; Southard JH; Belzer FO
    Swiss Surg; 1995; (4):205-9. PubMed ID: 9127638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
    Honn KV; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
    Prog Clin Biol Res; 1982; 89():295-331. PubMed ID: 7051034
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection.
    Khirabadi BS; Foegh ML; Ramwell PW
    Transplantation; 1985 Jan; 39(1):6-8. PubMed ID: 3880966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of renal allograft rejection].
    Michel F
    Ann Urol (Paris); 1988; 22(3):161-7. PubMed ID: 3041909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enzyme inhibitors and receptor antagonists in the arachidonic cascade].
    Arai Y; Kawamura M
    Nihon Rinsho; 1990 Jun; 48(6):1120-8. PubMed ID: 2166837
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of rat heart allograft rejection by urinary thromboxane.
    Foegh ML; Khirabadi BS; Shapiro R; Alijani MR; Goldman MH; Lower RR; Ramwell PW
    Transplant Proc; 1984 Dec; 16(6):1606-8. PubMed ID: 6390873
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukotrienes during rejection after canine pancreatic allotransplantation.
    Shimizu K; Izumi R; Horichi H; Yagi M; Hashimoto T; Watanabe T; Iyobe T; Iwasa K; Ii T; Fukushima W
    Transplant Proc; 1994 Aug; 26(4):2288-9. PubMed ID: 8066752
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.